Russian virosomal vaccine Efficacy and safety evaluation

Russian virosomal vaccine Efficacy and safety evaluation

Virosomal vaccines are new generation vaccines which activate humoral and cell-mediated immunity, induce stronger immunogenicity and sustain long-term protective immunity. The article tells about the results of clinical studies of the Russian next generation influenza vaccine Ultriks®, demoinstratin...

Full description

Bibliographic Details
Main Authors:	T. A. Grenkova, E. P. Selkova, N. V. Gudova
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2015-12-01
Series:	Медицинский совет
Subjects:	вакцинопрофилактика иммунитет безопасность грипп иммуногенность вакцина ультрикс® flu vaccine prevention immunity safety immunogenicity ultriks® vaccine
Online Access:	https://www.med-sovet.pro/jour/article/view/162

Similar Items

The Study in Animal Models of Local Action, Acute and Chronic Toxicity of Inactivated Influenza Vaccine Ultriks in Syringe
by: O. G. Kurskaya, et al.
Published: (2015-06-01)

POST-VACCINATION IMMUNE RESPONCE IN SERONEGATIVE TO INFLUENZA VIRUS HIV-INFECTED PATIENTS
by: R. G. Yapparov, et al.
Published: (2018-04-01)

NEW GENERATION DOMESTIC VACCINE FOR PROPHYLAXIS OF FLU
by: O. V. Shamsheva
Published: (2015-09-01)

Comparative Immunogenicity Evaluation of Characterized Chitosan-Based and Other Adjuvants for Inactivated Influenza Vaccines
by: L. M. Khantimirova, et al.
Published: (2016-02-01)

The Impact of Mass Immunization against Flu and Acute Respiratory Viral Infections on Epidemics Process in Sverdlovsk region
by: V. V. Romanenko, et al.
Published: (2016-02-01)

Safety and Immunogenicity of Fully Liquid Hexavalent DTaP-IPV-HepB-Hib Vaccine in Healthy Infants in Russian Federation
by: L. S. Namazova-Baranova, et al.
Published: (2019-06-01)

Immunoprophylaxis of Infectious Diseases in Russia: Condition and Perspective of Improvement
by: N. I. Brira, et al.
Published: (2017-04-01)

Epidemiology of hepatitis A and vaccination policy
by: I. N. Indikova, et al.
Published: (2018-02-01)

Immunogenicity and Protective Effect of Live Cold-Adapted Vaccines against Influenza B after Intranasal Immunization of Mice
by: O. S. Kashirina, et al.
Published: (2015-08-01)

The present vaccinoprophilaxis of tick-borne encephalitis and vaccines for its provision
by: M. S. Vorob’Eva, et al.
Published: (2006-12-01)

Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3)
by: Yu. H. Khapchaev, et al.
Published: (2017-06-01)

POTENTIAL OF THE RUSSIAN FEDERATION IN EXPORTS OF ANTI-INFLUENZA VACCINES IN LATIN AMERICAN COUNTRIES
by: V. P. Trukhin, et al.
Published: (2019-01-01)

Strengthening the Effectiveness of the Candidate Influenza Vaccine by Combining Conserved Sequences of Hemagglutinin and M2 protein
by: L. M. Tsybalova, et al.
Published: (2017-06-01)

Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study
by: L. S. Namazova-Baranova, et al.
Published: (2023-01-01)

Condition and Prospects of Development of Vaccines for Specific Prevention of Enterovirus (Nonpolio) Infection
by: E. A. Yagovkin, et al.
Published: (2016-08-01)

Results of Clinical Trials of the First Russian 4-valent Flu Vaccine
by: D. A. Lioznov
Published: (2018-09-01)

Experimental study of the protective effect of tuberculosis vaccines
by: D. T. Levy, et al.
Published: (2018-02-01)

Assessment of Reactogenicity and Immunogenicity of the Quadrivalent Live Attenuated Influenza Vaccine
by: D. A. Lioznov, et al.
Published: (2018-06-01)

The Relevance of Tetravalent Influenza Vaccines. World experience
by: A. D. M. E. Osterhaus
Published: (2018-09-01)

Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
by: Rodrigo Luiz Carregaro, et al.
Published: (2023-08-01)

The averted costs due to influenza vaccination with trivalent and quadrivalent vaccines
by: S. M. Kharit, et al.
Published: (2017-06-01)

THE PREVENTION OF ROTAVIRUS INFECTION: THE MODERN VIEW OF THE POSSIBILITY
by: T. A. Grechukha, et al.
Published: (2015-08-01)

Safety and Efficacy of a Subunit Vaccine against Flu Containing Polyoxidonium Systematic Review and Meta-Analysis of Clinical Trials
by: R. Kompier
Published: (2018-09-01)

A DTAP–IPV//PRP~T VACCINE: A REVIEW OF 16 YEARS’ CLINICAL EXPERIENCE
by: Stanley A. Plotkin, et al.
Published: (2012-01-01)

Post-Vaccination Immunity to Pertussis in Children of Lipetsk, New Management Capabilitiesto Infection
by: T. V. Timofeeva, et al.
Published: (2019-06-01)

The Impact Annual Immunization against Flu on Morbidity of Flu in the Russian Federation
by: A. Yu. Popova, et al.
Published: (2016-02-01)

Clinical and immunological efficacy of immunoprophylaxis of influenza in children with allergic diseases
by: E. G. Bokuchava, et al.
Published: (2016-12-01)

IMMUNOGENICITY AND SAFETY OF A TRIVALENT SUBUNIT IMMUNOADJUVANT INFLUENZA VACCINE IN CHILDREN WITH TYPE 1 DIABETES: RESULTS OF A PROSPECTIVE COMPARATIVE STUDY
by: Аlla A. Tarasova, et al.
Published: (2016-11-01)

100 Years after the Spanish Flu Pandemic. The Evolution of the Influenza Virus and the Development of the Flu Vaccine
by: N. I. Briko
Published: (2018-09-01)

Safety of Combination Vaccines with Whole Cell Pertussis Component
by: O. V. Perelygina, et al.
Published: (2016-12-01)

Immunogenicity of Modern Vaccine Viruses of Influenza A (H1N1)pdm09 According to Graphical Analysis
by: V. S. Vakin, et al.
Published: (2017-10-01)

Study of immunobiological properties of avian adenovirus serotype 2-based vaccine against adenovirus infection
by: A. A. Perepecha, et al.
Published: (2018-04-01)

Prospects of Using Domestic Hepatitis B Vaccines to Ensure Sanitary and Epidemiological Well-Being
by: I. V. Fel'dblyum
Published: (2017-08-01)

Polio Vaccines: Present and Future
by: K. Chumakov, et al.
Published: (2018-06-01)

Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years
by: I. V. Fel'dblyum, et al.
Published: (2018-02-01)

SAFETY AND IMMUNOLOGIC EFFICACY OF COMBINED IMMUNIZATION IN CHILDREN AGED 6—7 YEARS WITH VACCINES FROM THE NATIONAL CALENDAR OF PROPHYLACTICS VACCINES
by: I. V. Konovalov, et al.
Published: (2015-08-01)

INFLUENZA VACCINATION OF CHILDREN OF PRESCHOOL AGE IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS OF QUADRIVALENT VACCINE
by: A. V. Rudakova, et al.
Published: (2019-03-01)

Antidiphtheria immunity at children with allergic diseases
by: A V Labushkina, et al.
Published: (2009-12-01)

Modern approaches to the prevention of pneumococcal infection
by: S. M. Kharit, et al.
Published: (2015-12-01)

Evaluation of the preventive effectiveness of influenza vaccines in St. Petersburg
by: M. K. Erofeeva, et al.
Published: (2020-11-01)